Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 19,896 | 33,750 | 9,122 | 17,851 | 15,658 |
| Cost of Goods | 7,762 | 4,127 | 4,619 | 8,324 | 5,870 |
| Gross Profit | 12,134 | 29,623 | 4,503 | 9,527 | 9,788 |
| Operating Expenses | 8,224 | 8,604 | 9,780 | 7,720 | 9,486 |
| Operating Income | 4,672 | 21,146 | -4,658 | 2,131 | 1,172 |
| Other Income | 188 | -5 | -118 | 108 | -511 |
| Pre-tax Income | 4,860 | 21,141 | -4,776 | 2,239 | 661 |
| Income Tax | 1,083 | 2,824 | 728 | -116 | 497 |
| Net Income Continuous | 3,777 | 18,317 | -5,504 | 2,355 | 164 |
| Net Income | $3,777 | $18,317 | $-5,504 | $2,355 | $164 |
| EPS Basic Total Ops | 0.05 | 0.23 | -0.06 | 0.03 | 0.00 |
| EPS Basic Continuous Ops | 0.05 | 0.23 | -0.07 | 0.03 | 0.00 |
| EPS Diluted Total Ops | 0.05 | 0.22 | -0.06 | 0.03 | 0.00 |
| EPS Diluted Continuous Ops | 0.05 | 0.22 | -0.07 | 0.03 | 0.00 |
| EPS Diluted Before Non-Recurring Items | 0.05 | 0.22 | -0.07 | 0.03 | 0.00 |
| EBITDA(a) | $5,078 | $21,550 | $-4,271 | $2,503 | $1,532 |